Landmark Wealth Management (New York)’s Colgate-Palmolive CL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-950
Closed -$950 65
2022
Q1
$950 Buy
+950
New +$75.3K ﹤0.01% 105

Other funds holding CL

Landmark Wealth Management (New York)'s CL Position: Q2 2022 in Review

Landmark Wealth Management (New York) sold out of Colgate-Palmolive (CL) in Q2 2022, closing a stake of 950 shares — an estimated $950 sold.

Landmark Wealth Management (New York) first reported a position in CL in Q1 2022 and held it in 1 quarter. The position peaked at $950 in Q1 2022. 1,668 funds tracked by Wall St. Rank hold CL as of Q2 2022.

  • Landmark Wealth Management (New York) reported no remaining Colgate-Palmolive position as of Q2 2022 after selling out during the quarter.
  • Landmark Wealth Management (New York) sold 950 Colgate-Palmolive shares in Q2 2022, an estimated $950.
  • Landmark Wealth Management (New York) first reported a position in Colgate-Palmolive in Q1 2022 and held it in 1 quarter.
  • Landmark Wealth Management (New York)'s Colgate-Palmolive position peaked at $950 in Q1 2022.
  • 1,668 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q2 2022.

Based on Landmark Wealth Management (New York)'s 13F filing for Q2 2022, filed 21 Jul 2022.